The detection of Toxoplasma gondii ME49 infections in BALB/c mice using various techniques
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.
Abstract
Toxoplasma gondii infections are primarily diagnosed by serological assays, whereas molecular and fluorescence-based techniques are garnering attention for their high sensitivity in detecting these infections. Nevertheless, each detection method has its limitations. The toxoplasmosis detection capabilities of most of the currently available methods have not been evaluated under identical experimental conditions. This study aimed to assess the diagnostic potential of enzyme-linked immunosorbent assay (ELISA), real-time polymerase chain reaction (RT-PCR), immunohistochemistry (IHC), and immunofluorescence (IF) in BALB/c mice experimentally infected with various doses of T. gondii ME49. The detection of toxoplasmosis from sera and brain tissues was markedly enhanced in mice subjected to high infection doses (200 and 300 cysts) compared to those subjected to lower doses (10 and 50 cysts) for all the detection methods. Additionally, increased B1 gene expression levels and cyst sizes were observed in the brain tissues of the mice. Importantly, IHC, IF, and ELISA, but not RT-PCR, successfully detected T. gondii infections at the lowest infection dose (10 cysts) in the brain. These findings may prove beneficial while designing experimental methodologies for detecting T. gondii infections in mice.
참고문헌 (28)
- Sacks D, "Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke", Int J Stroke, 13(6), pp.612~632 (2018)[DOI]
- Nayeri T, "Toxoplasmosis : targeting neurotransmitter systems in psychiatric disorders", Metab Brain Dis, 37(1), pp.123~146 (2022)[DOI]
- Jones JL, "Risk factors for Toxoplasma gondii infection in the United States", Clin Infect Dis, 49(6), pp.878~884 (2009)[DOI]
- Suzuki Y, "Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells", Am J Pathol, 176(4), pp.1607~1613 (2010)[DOI]
- Torres L, "Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer’s disease in wild-type, C57BL", 6 mice, 2018, pp.15(1), 57~
- Evangelista FF, "Rosuvastatin revert memory impairment and anxiogenic-like effect in mice infected with the chronic ME-49strain of Toxoplasma gondii", PLoS One, 16(4), pp.e0250079~ (2021)[DOI]
- Hegazy MK, "Detection of chronic toxoplasmosis in the brain of mice using loop-mediated isothermal amplification(LAMP)and conventional PCR", Exp Parasitol, 251, pp.108556~ (2023)[DOI]
- Rahumatullah A, "Triplex PCR using new primers for the detection of Toxoplasma gondii", Exp Parasitol, 131(2), pp.231~238 (2012)[DOI]
- Bezerra ECM, "Behavioral evaluation of BALB", c(Mus musculus)mice infected with genetically distinct strains of Toxoplasma gondii, 2019, pp.126, 279~286
- Kikuchi T, "Kinetics of the nucleoside triphosphate hydrolase of Toxoplasma gondii in mice with acute and chronic toxoplasmosis", Ann Trop Med Parasitol, 96(1), pp.35~41 (2002)[DOI]
- Rahumatullah A, "Development of triplex real-time PCR and detection of Toxoplasma gondii DNA in infected mice tissues and spiked human samples", Trop biomed, 32(2), pp.376~385 (2015)
- Piña-Vázquez C, "A quantitative competitive PCR method to determine the parasite load in the brain of Toxoplasma gondii-infected mice", Parasitol Int, 57(3), pp.347~353 (2008)[DOI]
- Yoon KW, "Mucosal administration of recombinant baculovirus displaying Toxoplasma gondii ROP4 confers protection against T. gondii challenge infection in mice", Front Cell Infect Microbiol, 11, pp.735191~ (2021)[DOI]
- Kang HJ, "Influenza virus-like particles presenting both Toxoplasma gondii ROP4and ROP13 enhance protection against T. gondii infection", Pharmaceutics, 11(7), pp.342~ (2019)[DOI]
- Chu KB, "Advances in Toxoplasma gondii vaccines : current strategies and challenges for vaccine development", Vaccines(Basel), 9(5), pp.413~ (2021)[DOI]
- Dubey JP, "Outbreaks of clinical toxoplasmosis in humans : five decades of personal experience, perspectives and lessons learned", Parasit Vectors, 14(1), pp.263~ (2021)[DOI]
- Karshima SN, "Human Toxoplasma gondii infection in Nigeria : a systematic review and meta-analysis of data published between 1960 and 2019", BMC Public Health, 20(1), pp.877~ (2020)[DOI]
- Strang A, "The congenital toxoplasmosis burden in Brazil : systematic review and meta-analysis", Acta Trop, 211, pp.105608~ (2020)[DOI]
- Rostami A, "Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection", Infection, 46(3), pp.303~315 (2018)[DOI]
- Ferra BT, "The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera", PLoS One, 14(6), pp.e0217866~ (2019)[DOI]
- Attias M, "The life-cycle of Toxoplasma gondii reviewed using animations", Parasit Vectors, 13(1), pp.588~ (2020)[DOI]
- Watson GF, "Systematic review and meta-analysis of variation in Toxoplasma gondii cyst burden in the murine model", Exp Parasitol, 196, pp.55~62 (2019)[DOI]
- Di Cristina M, "Temporal and spatial distribution of Toxoplasma gondii differentiation into bradyzoites and tissue cyst formation in vivo", Infect Immun, 76(8), pp.3491~3501 (2008)[DOI]
- Suzuki Y, "IFN-γ production by brain-resident cells activates cerebral mRNA expression of a wide spectrum of molecules critical for both innate and T cell-mediated protective immunity to control reactivation of chronic infection with Toxoplasma gondii", Front Cell Infect Microbiol, 13, pp.1110508~ (2023)[DOI]
- Miwa Sasai, "Innate, adaptive, and cell-autonomous immunity against Toxoplasma gondii infection", Experimental and Molecular Medicine, 51, pp.1~10 (2019), 생화학분자생물학회[DOI]
- Schlüter D, "Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain", Am J Pathol, 150(3), pp.1021~1035 (1997)
- Araujo FG, "Demonstration of Trypanosoma cruzi antigen in serum from patients with Chagas’ disease", Lancet, 1(8214), pp.246~249 (1981)[DOI]
- Kim MJ, "Virus-like particle vaccine displaying Toxoplasma gondii apical membrane antigen 1 induces protection against T. gondii ME49 infection in mice", Microb Pathog, 142, pp.104090~ (2020)[DOI]